back in the u.s., we told former fda commissioner david kessler what we learned about india's drug researchfied a real issue. a real problem that's only going to increase. >> and kessler says the problem is not just with foreign drug testing, something we discovered when that new jersey review board approved our plan to test a drug identical to vioxx on humans. >> this is as much an issue, sometimes in the united states. don't feel that there's no problem here at home. >> so with all the holes we found in the drug safety net from the review board in new jersey, to the research companies in india can we still be confident the medicines we take are properly tests and safe? the pharmaceutical industry's lead trade group declined to talk to us, but in the past it's called the u.s. drug approval process second to none. the director of the association of clinical research organizations also defends the industry's track record. >> concerns notwithstanding, on the whole, the clinical research enterprise is amazingly safe and amazingly productive. >> he says there is too much at stake for the indust